Abstract:N-cadherin serves as an important oncobiomarker of epithelial-to-mesenchymal transition (EMT) progression, which identifies invasion and metastasis of malignant tumor cells. Although many efforts have been devoted to quantitative detection of N-cadherin, efforts to analyzing the protein of interest at intact cellular levels are scarce. Herein, a metal cluster-based electrochemical biosensing system is developed to determine the expressing levels of N-cadherin during the EMT process of tumor cells. To be specific, a peptide with a unique sequence and function is designed as a reductant and an anchor to synthesize metal clusters in a precise manner. Consequently, peptide-modified metal clusters possess N-cadherin-targeting, photoluminescence, and electrocatalytic properties. Especially, the redox-active metal clusters function as both an electron-transfer mediator and an electronic conductor for enhanced electrochemical sensing. These favorable features enable them as a rapid, sensitive, and reliable whole-cell biosensor, which integrates the fluorescence and electrochemical signals. This cytosensor can accurately quantify the expression levels of N-cadherin on at least 5000 tumor cells. Further, the current signals of model cancer cells gradually increase with EMT progression, indicating tumor cell-type evolution. Our study represents the advanced bioprobe and analytical methods for accurate quantitation of a biomarker to identify tumor progression.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.1c00339?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.1c00339</a>.The formula of quantitative calculation, the stability of AuCs, optimization of conditions of cells labeled with AuCs, optimization of electrochemical test conditions, the influence of pH changes on the current signal, the characterization of the surface morphology and the structure of the modified electrode, the effect of pure cells on the current signal, and quantitative analysis of N-cadherin in CaSki cells with lower N-cadherin levels (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.1c00339/suppl_file/se1c00339_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Constructing a Highly Sensitive Duplex Immunoassay Using AuNPs and AgNPs As Nanolabels for Investigating the Epithelial-Mesenchymal Transition Occurring on Circulating Tumor Cells with Lung Cancer Patients

Tracking epithelial-mesenchymal transition in breast cancer cells based on a multiplex electrochemical immunosensor

Metal Cluster-Based Electrochemical Biosensing System for Detecting Epithelial-to-Mesenchymal Transition

A Novel Label-Free and Reusable Electrochemical Cytosensor for Highly Sensitive Detection and Specific Collection of CTCs

Multiplex Sensing of Biomarkers on the Cancer Cell Surface by an Epithelial-Mesenchymal Transition (EMT) Sensing Panel Enables Precise Differentiating of Cancer Cells at Various EMT Stages

A Novel Electrochemiluminescent Cytosensor Using Dual-Target Magnetic Probe Recognition and Nanozymes-Catalyzed Cascade Signal Amplification for Precise Phenotypic Enumeration of CTCs

Multifunctional Gold Nano-Cytosensor With Quick Capture, Electrochemical Detection, and Non-Invasive Release of Circulating Tumor Cells for Early Cancer Treatment

An electrochemical immunosensor for simultaneous multiplexed detection of two lung cancer biomarkers using Au nanoparticles coated resin microspheres composed of L-tryptophan and caffeic acid

Electrochemiluminescence Immunosensor for Tumor Markers Based on Biological Barcode Mode with Conductive Nanospheres.

Ratiometric Electrochemiluminescence Detection of Circulating Tumor Cells and Cell-Surface Glycans

Dual-Multivalent-Aptamer-Conjugated Nanoprobes for Superefficient Discerning of Single Circulating Tumor Cells in a Microfluidic Chip with Inductively Coupled Plasma Mass Spectrometry Detection.

Ultrasensitive Detection of Circulating Tumor Cells in Clinical Blood Samples by a Three-Dimensional Network Nanovehicle-Based Aptasensor Platform

Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer

Nonenzymatic Amperometric Aptamer Cytosensor for Ultrasensitive Detection of Circulating Tumor Cells and Dynamic Evaluation of Cell Surface N-Glycan Expression

Electrochemical Cytosensor Utilizing Tetrahedral DNA/bimetallic AuPd Holothurian-Shaped Nanoparticles for Ultrasensitive Non-Destructive Detection of Circulating Tumor Cells

Electrochemical Stripping Analysis of Nanogold Label-Induced Silver Deposition for Ultrasensitive Multiplexed Detection of Tumor Markers.

High Luminous Efficiency Au@CDs for Sensitive and Label-Free Electrochemiluminescent Detection of Circulating Tumor Cells in Serum

Highly specific electrochemical analysis of cancer cells using multi-nanoparticle labeling.

A amperometric immunosensor for sensitive detection of circulating tumor cells using a tyramide signal amplification-based signal enhancement system.

Sensitive Electrochemical Aptasensor for Detecting EpCAM with Silica Nanoparticles and Quantum Dots for Signal Amplification

Multiplexing determination of lung cancer biomarkers using electrochemical and surface-enhanced Raman spectroscopic techniques